Global Cardiovascular Disease Monitoring and Diagnostic Devices Strategic Business Report 2023: Increasing Preference for Homecare Drives Cardiac Monitoring Devices Demand

Company Logo

Global Market for Cardiovascular Disease Monitoring and Diagnostic Devices

Global Market for Cardiovascular Disease Monitoring and Diagnostic Devices

Dublin, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The "Cardiovascular Disease Monitoring and Diagnostic Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for Cardiovascular Disease Monitoring and Diagnostic Devices estimated at US$2.5 Billion in the year 2022, is projected to reach a revised size of US$3.6 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2022-2030.

ECG Systems, one of the segments analyzed in the report, is projected to record a 5.2% CAGR and reach US$1.4 Billion by the end of the analysis period.

Taking into account the ongoing post pandemic recovery, growth in the Holter Monitors segment is readjusted to a revised 5.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $684.6 Million, While China is Forecast to Grow at 8% CAGR

The Cardiovascular Disease Monitoring and Diagnostic Devices market in the U.S. is estimated at US$684.6 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$783.4 Million by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.5% and 5.3% respectively over the 2022-2030 period.

Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$491.2 Million by the year 2030.

What`s New for 2023?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

• Global competitiveness and key competitor percentage market shares

• Market presence across multiple geographies - Strong/Active/Niche/Trivial

• Online interactive peer-to-peer collaborative bespoke updates

• Access to digital archives and Research Platform

• Complimentary updates for one year

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

• Influencer Market Insights

• World Market Trajectories

• Cardiovascular Diseases: Facts & Figures

• Recent Market Activity

• CVD Monitoring and Diagnostic Devices on a High Growth Trajectory

• The US Dominates, Asia-Pacific to Witness Fastest Growth

• ECG Systems Lead the CVD Diagnostics and Monitoring Market

• Competitive Scenario

• Holter Monitoring Systems: An Established Market, Facing Threats

• Ambulatory Cardiac Monitoring Devices - A Comparison of Holter and Other Devices

• Evolution of Cardiac Monitoring Devices

• A Comparison of Key Features of Three Major Ambulatory ECG Systems- Holter Monitoring, Event Monitoring and MCOT

• Benefits and Drawbacks of Three Major Primary Cardiac Event Monitoring Systems - Holter Monitoring, Event Monitoring and MCOT

• Competitive Landscape

• ImplanTable Loop Recorder (ILR) to Register the Fastest Growth

• ECG Management Systems: Integral for Data Storage

• Impact of Covid-19 and a Looming Global Recession

• Cardiovascular Disease Monitoring and Diagnostic Devices - Global Key Competitors Percentage Market Share in 2022 (E)

• Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

• BioTelemetry, Inc. (USA)

• BIOTRONIK SE & Co. KG (Germany)

• Boston Scientific Corporation (USA)

• GE Healthcare UK Ltd. (UK)

• Koninklijke Philips N.V, (USA)

• Medtronic Plc. (USA)

• Mortara Instrument, Inc. (USA)

• Nihon Kohden Corporation (Japan)

• Philips Healthcare (USA)

• Schiller AG (Switzerland)

• Spacelabs Healthcare, Inc. (USA)

• St. Jude Medical, Inc. (USA)

• Welch Allyn (USA)

3. MARKET TRENDS & DRIVERS

• Global Menace of Cardiovascular Disease (CVD) - A Major Growth Driver

• Aging Population Drives Demand

• Increase in Healthcare Spending Bodes Well for Cardiac Monitoring Market

• Risk of CAD in Obesity Offers Prospects for Cardiac Monitoring Devices

• Diabetics at Higher Risk of Heart Diseases

• Increasing Preference for Homecare Drives Cardiac Monitoring Devices Demand

• SELECT PRODUCT TRENDS/ADVANCEMENTS

• Holter Devices Continue to Witness Technological Advances

• Disposable Devices - the New Trend in Holter Monitors

• ZIO Wireless Patch Holter Monitors

• Mobile Cardiac Telemetry (MCT): A Potential Threat to Holter Monitors

• Remote Monitoring Reduces Hospital Admissions and Readmissions

• Innovations in Remote ECG Monitoring

• Advancements in ECG Management Systems

• Third-Party Integration

• GE Muse Version 9 ECG Management System

• Mobile Access for ECG Waveforms

• Others Advancements in ECG Management Systems

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/t6ks8y

Attachment

• Global Market for Cardiovascular Disease Monitoring and Diagnostic Devices

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900